NCT05626985View on ClinicalTrials.gov

Refinement and Validation of a Diagnostic Model (GAMAD) for Early Detection of Hepatocellular Carcinoma

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

October 19, 2022

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2024

Conditions
Hepatocellular Carcinoma
Interventions
DIAGNOSTIC_TEST

GAMAD

Blood samples are tested for tumor markers including PIVKA-II (DCP),AFP, ctDNA methylation and biochemical tests.

Trial Locations (3)

Unknown

RECRUITING

The First Hospital of Jilin University, Jilin

RECRUITING

Eastern Hepatobiliary Surgery Hospital, Shanghai

RECRUITING

Tianjin Third Central Hospital, Tianjin

All Listed Sponsors
collaborator

The First Hospital of Jilin University

OTHER

lead

Singlera Genomics Inc.

INDUSTRY